PAVAJ Vascular Selects Ascendia Pharmaceuticals to perform biomanufacturing. Posted on September 5, 2025September 5, 2025 by pavaj
PAVAJ Vascular obtains SBIR Phase 2 NIH grant R44DK13981 to start Biomanufacturing of 1,25 NPs. Posted on September 5, 2025September 5, 2025 by pavaj
